How two companies sprinted ahead in extraordinary race for a COVID vaccine
“He did not want us to focus on the potential barriers we might face, but instead said that it is much better to try to do something that seemed impossible, and even if you don’t succeed, you still (will) have done something great, ” said Dormitzer, noting that new vaccine development can cost on the

Full story is loading. Click here if it doesn't...

Advertisement